Yasin Keshvargar
Lawyers
Filters
Inventiva private placement of up to €348 million
The offering includes ordinary shares, pre-funded warrants and warrants
Immatics $150 million follow-on offering
We advised Immatics on the offering of shares
Labcorp $2 billion senior notes offering
The investment-grade notes are due 2030, 2032 and 2034
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Terns Pharmaceuticals $173 million stock and pre-funded warrants offering
The shares are listed on the Nasdaq Global Select Market
Eli Lilly $5 billion notes offering
The investment-grade notes are due 2027, 2029, 2034, 2054 and 2064
ANI Pharmaceuticals $316.25 million convertible notes offering
We advised ANI Pharmaceuticals on the offering
Walgreens Boots Alliance $750 million notes offering
We advised Walgreens Boots Alliance on its debt offering
Precigen $34 million follow-on offering
We advised Precigen on the SEC-registered offering
Generation Bio $237 million at-the-market offering
The shares are listed on Nasdaq